Alpha Tau Medical (DRTSW) Accumulated Depreciation (2020 - 2025)
Alpha Tau Medical (DRTSW) posted Accumulated Depreciation of $5.3 million for Q4 2025, up 30.1% sequentially from $4.1 million in Q4 2024, and up 30.1% YoY from $4.1 million in Q4 2024.
Alpha Tau Medical (DRTSW) Accumulated Depreciation (2020 - 2025) Analysis & Trends
Alpha Tau Medical has reported Accumulated Depreciation for 5 years, with the latest figure at $5.3 million in Q4 2025.
- Quarterly Accumulated Depreciation rose 30.1% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.3 million (up 30.1% YoY) and the FY2025 annual result came in at $5.3 million, up 30.1% from the prior year.
- Accumulated Depreciation rose to $5.3 million in Q4 2025 per DRTSW's latest filing, from $4.1 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $5.3 million in Q4 2025 and troughed at $912000.0 in Q4 2021.
- A 4-year average of $3.3 million and a median of $3.5 million in 2023 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2021 and 2025: Accumulated Depreciation surged 436.47% in 2021, then soared 30.1% in 2025.
- Over 4 years, Accumulated Depreciation stood at $912000.0 in 2021, then soared by 225.11% to $3.0 million in 2023, then jumped by 36.69% to $4.1 million in 2024, then jumped by 30.1% to $5.3 million in 2025.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $5.3 million, $4.1 million, and $3.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alpha Tau Medical | 383.00 Mn | 200.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.27 Mn |
| Dec 31, 2024 | 4.05 Mn |
| Dec 31, 2023 | 2.97 Mn |
| Dec 31, 2021 | 912,000.00 |
| Dec 31, 2020 | 170,000.00 |